- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Stronger Bulwarks in the War on Cancer
23 July 1997 7:00 pm
Pledging to beef up two areas of cancer research--prevention and behavioral studies--the nation's general in the war on cancer, Richard Klausner, today announced a new plan that raises the stature of those research areas at the organization he heads, the $2.3 billion National Cancer Institute (NCI).
Cancer prevention includes things like diet and early detection programs, while "control" research encompasses studies of special populations, outcomes, and behavior--why some women are more likely than others to get mammograms, for example. Klausner's plan will split in half the Division of Cancer Prevention and Control, the branch of NCI that now deals with these two areas. One division, Cancer Control and Population Science, will be headed by Duke University behavioral scientist Barbara Rimer, who will resign as head of the National Cancer Advisory Board to take the job on 1 October. Klausner says he plans a national search for a chief for the other branch, Cancer Prevention.
"There will be new programs built in both" divisions, says Klausner. For example, "I'm really looking to strengthen behavioral research." And in the prevention area, he says, new research may include more work on "vaccines or other preventive measures aimed at infectious agents that contribute to cancer."